Syndax Pharmaceuticals Inc Underwriting Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated December 14, 2023, by and between the Company and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2023
Underwriting Agreement, dated December 6, 2022, by and between the Company and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2022
Underwriting Agreement, dated December 15, 2021, by and among the Company and Goldman Sachs & Co. LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2021
Underwriting Agreement, dated December 8, 2020, by and among the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2020
Underwriting Agreement, dated April 30, 2020, by and among the Company, Citigroup Global Markets Inc. and Cowen and Company, LLC
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2020
3,750,000 Shares SYNDAX PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
NY
2017
Shares Syndax Pharmaceuticals, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT
Underwriting Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016